Articles
19.01.2026
If You’re a Market Access Lead in 2026: How to...

The year 2026 marks a significant milestone for the European Union’s (EU) Health Tec...

Read more
Articles
12.01.2026
If You’re a Market Access Lead in 2026: What W...

Have you ever wondered what separates the organisations that consistently secure unhindere...

Read more
Articles
03.12.2025
Market Access & Pricing Trends for 2026

The Top Market Access Trends for 2026 The market access trends 2026 are being shaped by increasing g...

Read more
Articles
26.11.2025
2025 Market Access Check-In: Evaluating the Impact...

2025 was a pivotal year for market access, marked by the growing convergence between scientific inno...

Read more
Articles
03.11.2025
Designing Payer-Ready Trials in 2025: Five Decisio...

Clinical innovation has never moved faster. Tools like single-arm designs, novel surrogates, and ada...

Read more
Articles
21.10.2025
Comparator Choice: The Question That Defines Marke...

Every payer ultimately asks the same question: “Compared with what?” This single question shapes...

Read more
Articles
13.10.2025
Surrogates Under Scrutiny: Proving the Link to Out...

Surrogate Endpoints in HTA Decision-Making The need to stay ahead of competitors and offset losses f...

Read more
Articles
08.10.2025
Orchestrating Evidence Needs: Overcoming Regulator...

Optimising evidence generation in trial design, while navigating regulatory and local payer requirem...

Read more
Articles
01.10.2025
MFN Drug Pricing Proposal: What It Could Mean for ...

Negotiations between the Trump administration and pharmaceutical companies on lowering U.S...

Read more
Articles
29.09.2025
Your 5-step ATMP pricing playbook for launch succe...

Advanced Therapy Medicinal Products (ATMPs) are offering transformative, and often life-saving, trea...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.